Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis

被引：0
|
作者：
Arents, Bernd W. M. [1 ]
机构：
[1] Dutch Assoc People Atop Dermatitis, Nijkerk, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷 / 06期
关键词：
D O I：
10.1093/bjd/ljad068
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：694 / 694
页数：1
相关论文
共 50 条
  • [31] The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, Bader
    Alzahrani, Ziyad
    Samarkandy, Sahal
    Aman, Abdullah
    Jfri, Abdulhadi
    FRONTIERS IN MEDICINE, 2023, 9
  • [32] Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment
    Silverberg, Jonathan I.
    Wollenberg, Andreas
    Stein Gold, Linda
    Del Rosso, James
    Yosipovitch, Gil
    Lio, Peter
    Carrascosa, Jose-Manuel
    Gallo, Gaia
    Ding, Yuxin
    Xu, Zhenhui
    Casillas, Marta
    Pierce, Evangeline
    Agell, Helena
    Staender, Sonja
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2249 - 2260
  • [33] Treating moderate-to-severe atopic dermatitis: what do dermatologists do with limited evidence?
    Drucker, A. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (06) : 1441 - 1442
  • [34] Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
    Ameen, Mahreen
    Alhusaye, Raed
    Brandi, Henrik
    Bogelund, Mette
    Jensen, Henrik H.
    Reitzel, Signe B.
    Thyssen, Jacob P.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [35] Abrocitinib: a potential treatment for moderate-to-severe atopic dermatitis
    Nezamololama, Novin
    Crowley, Erika L.
    Gooderham, Melinda J.
    Papp, Kim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (09) : 911 - 917
  • [36] Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
    Lio, Peter A.
    Armstrong, April
    Gutermuth, Jan
    Nosbaum, Audrey
    Sofen, Howard
    Gil, Esther Garcia
    Casillas, Marta
    Chen, Sherry
    Sun, Luna
    Pierce, Evangeline
    Elmaraghy, Hany
    Dawson, Zach
    Torres, Tiago
    DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1929 - 1943
  • [37] Symptom burden of patients with moderate-to-severe atopic dermatitis
    Alexander Egeberg
    Peter Anderson
    James Piercy
    Lucy Massey
    Joseph C. Cappelleri
    Gerardo A. Encinas
    Claire Feeney
    Marco Dibonaventura
    European Journal of Dermatology, 2021, 31 : 752 - 758
  • [38] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    Beck, Lisa A.
    Thaci, Diamant
    Hamilton, Jennifer D.
    Graham, Neil M.
    Bieber, Thomas
    Rocklin, Ross
    Ming, Jeffrey E.
    Ren, Haobo
    Kao, Richard
    Simpson, Eric
    Ardeleanu, Marius
    Weinstein, Steven P.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    Suarez-Farinas, Mayte
    Hager, Melissa D.
    Stahl, Neil
    Yancopoulos, George D.
    Radin, Allen R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139
  • [39] Symptom burden of patients with moderate-to-severe atopic dermatitis
    Egeberg, Alexander
    Anderson, Peter
    Piercy, James
    Massey, Lucy
    Cappelleri, Joseph C.
    Encinas, Gerardo A.
    Feeney, Claire
    Dibonaventura, Marco
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (06) : 752 - 758
  • [40] Lebrikizumab Combined with Topical Corticosteroids Improves Patient- reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis
    Tanaka, Akio
    Igawa, Ken
    Takahashi, Hidetoshi
    Shimizu, Ryosuke
    Kataoka, Yoko
    Torisu-Itakura, Hitoe
    Morisaki, Yoji
    Montmayeur, Sonia
    Katoh, Norito
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
12345